Passage Bio Future Growth

How is Passage Bio forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


9.5%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGS:PASG - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20255-127-123-1306
12/31/20240-136-99-1277
12/31/2023N/A-124-92-1208
9/30/2022N/A-160-137-125N/A
6/30/2022N/A-180-165-143N/A
3/31/2022N/A-189-167-141N/A
12/31/2021N/A-185-153-127N/A
9/30/2021N/A-173-145-126N/A
6/30/2021N/A-155-110-102N/A
3/31/2021N/A-134-92-89N/A
12/31/2020N/A-112-82-81N/A
9/30/2020N/A-86-69-69N/A
6/30/2020N/A-69-63-62N/A
3/31/2020N/A-56-62-62N/A
12/31/2019N/A-46-42-40N/A
9/30/2019N/A-38-45-41N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PASG is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: PASG is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: PASG is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: PASG is forecast to have no revenue next year.

High Growth Revenue: PASG is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: PASG is forecast to be unprofitable in 3 years.


Discover growth companies